12 results match your criteria: "Medecins Sans Frontieres (Operational Centre Geneva)[Affiliation]"
J Glob Antimicrob Resist
September 2022
Médecins Sans Frontières - MSF Lebanon Branch Office, Middle East Medical Unit, Beirut, Lebanon; Médecins Sans Frontières - Operational Centre Brussels, Operations Department, Brussels, Belgium.
JAC Antimicrob Resist
September 2021
MSFOCB Operations Department Cell 3, Brussels, Belgium.
Objectives: WHO recommends HIV self-testing (HIVST) as an additional approach to HIV testing services. The study describes the strategies used during phase-in of HIVST under routine conditions in Eswatini (formerly Swaziland).
Methods: Between May 2017 and January 2018, assisted and unassisted oral HIVST was offered at HIV testing services (HTS) sites to people aged ≥ 16 years.
J Int AIDS Soc
March 2020
Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Introduction: The Treat-All policy - antiretroviral therapy (ART) initiation irrespective of CD4 cell criteria - increases access to treatment. Many ART programmes, however, reported increasing attrition and viral failure during treatment expansion, questioning the programmatic feasibility of Treat-All in resource-limited settings. We aimed to describe and compare programmatic outcomes between Treat-All and standard of care (SOC) in the public sectors of Eswatini.
View Article and Find Full Text PDFJ Int AIDS Soc
October 2019
Médecins Sans Frontières (Operational Centre Geneva), Geneva, Switzerland.
Introduction: The World Health Organization recommends the Treat-All policy of immediate antiretroviral therapy (ART) initiation, but questions persist about its feasibility in resource-poor settings. We assessed the feasibility of Treat-All compared with standard of care (SOC) under routine conditions.
Methods: This prospective cohort study from southern Eswatini followed adults from HIV care enrolment to ART initiation.
Trop Med Int Health
October 2019
Medecins Sans Frontieres (Operational Centre Geneva), Geneva, Switzerland.
Objectives: Provision of drug-resistant tuberculosis (DR-TB) treatment is scarce in resource-limited settings. We assessed the feasibility of ambulatory DR-TB care for treatment expansion in rural Eswatini.
Methods: Retrospective patient-level data were used to evaluate ambulatory DR-TB treatment provision in rural Shiselweni (Eswatini), from 2008 to 2016.
Trop Med Int Health
September 2019
Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Objectives: This paper assesses patient- and population-level trends in TB notifications during rapid expansion of antiretroviral therapy in Eswatini which has an extremely high incidence of both TB and HIV.
Methods: Patient- and population-level predictors and rates of HIV-associated TB were examined in the Shiselweni region in Eswatini from 2009 to 2016. Annual population-level denominators obtained from projected census data and prevalence estimates obtained from population-based surveys were combined with individual-level TB treatment data.
Trop Med Int Health
June 2019
Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Objectives: To assess long-term antiretroviral therapy (ART) outcomes during rapid HIV programme expansion in the public sector of Eswatini (formerly Swaziland).
Methods: This is a retrospectively established cohort of HIV-positive adults (≥16 years) who started first-line ART in 25 health facilities in Shiselweni (Eswatini) between 01/2006 and 12/2014. Temporal trends in ART attrition, treatment expansion and ART coverage were described over 9 years.
Lancet Infect Dis
March 2017
Department of Infection, University College London, London, UK; Africa Health Research Institute, KwaZulu Natal, South Africa. Electronic address:
Background: HIV-1 drug resistance to older thymidine analogue nucleoside reverse transcriptase inhibitor drugs has been identified in sub-Saharan Africa in patients with virological failure of first-line combination antiretroviral therapy (ART) containing the modern nucleoside reverse transcriptase inhibitor tenofovir. We aimed to investigate the prevalence and correlates of thymidine analogue mutations (TAM) in patients with virological failure of first-line tenofovir-containing ART.
Methods: We retrospectively analysed patients from 20 studies within the TenoRes collaboration who had locally defined viral failure on first-line therapy with tenofovir plus a cytosine analogue (lamivudine or emtricitabine) plus a non-nucleoside reverse transcriptase inhibitor (NNRTI; nevirapine or efavirenz) in sub-Saharan Africa.
PLoS One
January 2016
Médecins Sans Frontières (Operational Research Unit), Luxembourg, Luxembourg.
Introduction: This study explores factors associated with virological detectability, and viral re-suppression after enhanced adherence counselling, in adults and children on antiretroviral therapy (ART) in Swaziland.
Methods: This descriptive study used laboratory data from 7/5/2012 to 30/9/2013, which were linked with the national ART database to provide information on time on ART and CD4 count; information on enhanced adherence counselling was obtained from file review in health facilities. Multivariable logistic regression was used to explore the relationship between viral load, gender, age, time on ART, CD4 count and receiving (or not receiving) enhanced adherence counselling.
J Acquir Immune Defic Syndr
September 2014
*Médecins Sans Frontières (Operational Centre Geneva), Mbabane, Swaziland; †Swaziland National AIDS Program, Ministry of Health, Mbabane, Swaziland; ‡Swaziland National Reference Laboratory, Mbabane, Swaziland; §Médecins Sans Frontières (Operational Centre Geneva), Geneva, Switzerland; ‖Institute of Tropical Medicine, Antwerp, Belgium; and ¶Médecins Sans Frontières (Operational Research Unit, MSF Luxembourg), Luxembourg.
Objective: To assess the programmatic quality (coverage of testing, counseling, and retesting), cost, and outcomes (viral suppression, treatment decisions) of routine viral load (VL) monitoring in Swaziland.
Design: Retrospective cohort study of patients undergoing routine VL monitoring in Swaziland (October 1, 2012 to March 31, 2013).
Results: Of 5563 patients eligible for routine VL testing monitoring in the period of study, an estimated 4767 patients (86%) underwent testing that year.
BMC Int Health Hum Rights
April 2011
Médecins Sans Frontières (Operational Centre Geneva), 78 rue de Lausanne, CH-1211 Genève 21, Switzerland.
Background: The war in eastern Democratic Republic of Congo has been the subject of numerous studies related to the problem of sexual violence. Historically, such violence is known to be part of strategic war plans to conquer and destroy communities, but it is now unfortunately prevalent in times of relative calm.
Methods: We describe the characteristics and consequences of sexual violence in Ituri province of Democratic Republic of Congo through the retrospective analysis of 2,565 patients who received medical care in the Médecins Sans Frontières sexual violence clinic in the capital of Ituri province, Bunia, between September 2005 and December 2006.